Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. - Test2 - elhamkhani - TriplyDB

Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

http://www.wikidata.org/entity/Q33511706

about

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis Autophagy modulation as a potential therapeutic target for diverse diseases Clonal relationship and differentiation among Mycobacterium abscessus isolates as determined using the semiautomated repetitive extragenic palindromic sequence PCR-based DiversiLab system.Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA.Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.Conditional gene expression in Mycobacterium abscessus.Clinical significance of microbial infection and adaptation in cystic fibrosis.Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients Mycobacterium abscessus multispacer sequence typing.Multiple cases of cutaneous Mycobacterium massiliense infection in a "hot spa" in Japan Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains.Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice.Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry.The genome sequence of 'Mycobacterium massiliense' strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report.Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates Prevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France.MycoBASE: expanding the functional annotation coverage of mycobacterial genomes.Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications Principal component analysis of MALDI TOF MS mass spectra separates M. abscessus (sensu stricto) from M. massiliense isolates.Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009.Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis.MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection.Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages.Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR.High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks Nontuberculous mycobacterial pulmonary infections

P2860

Q24187458-9D32281F-DFF0-4576-8C3D-30384747E29C Q24202353-B0842668-54DA-4C51-9CDA-7A9C7FB7052D Q24202502-C0DDEA5C-A8C7-4C69-868C-EFC7C560CDF8 Q26775974-061ED6B2-4179-4232-B385-3B06A21831AB Q27010076-E540542F-0F4A-4E0B-B3C2-7865410C716A Q33703455-B8963B25-A021-4571-8E75-030439EBE693 Q33792765-3A4A7CF5-4522-4D30-A0FC-30238B2F7CAA Q33798263-7782F07D-C54B-432A-913C-4DE50B4D3FBA Q34010278-427DD4A5-8108-48D3-BBB1-7B80BB5340AB Q34058548-D5633ED4-AC19-4CDC-8768-0C48CDCE83B0 Q34110899-0E9292F4-FC88-474A-BC15-D8A70B0BFEF3 Q34491552-0DC08B32-8643-415E-8C2B-25F7D02DF461 Q34528945-FE6CE4FF-31A3-4A5C-9BE2-6BE6EC37FBA8 Q34537770-9BDF1C92-6CF8-4E12-93AE-B6FD31C3C545 Q34538162-BF1BAC57-BFBD-4A89-9682-5229CD275FE8 Q34596565-0B9BAD9D-28F2-4F45-AB0D-5DE8D57DA1D6 Q34596782-16BCF1C7-0422-4B8B-B38B-0C1F0FB332C1 Q34955688-08C215F3-EF2A-412F-BF0E-4D08F50666F0 Q35035791-134C0931-1DB9-4E0C-A3AB-5A6BB8A02915 Q35060598-A9E4E394-2EC3-45EB-8624-A5A98AD0104E Q35298968-4190EE44-42A2-46B7-9395-24185958D139 Q35749256-18D1F89C-91F9-4756-B1F3-9759A661844E Q35822245-6A8BF0CC-67CC-46DF-B496-AB2A376070E0 Q35878545-50B32E1F-C414-4413-B810-8DAFFF4C4879 Q35925603-1A0699EC-9378-41F8-8010-3DB628BD22F4 Q35939699-19D6B770-3039-4994-9C06-901253C2427F Q36075849-D879B19A-90E4-4F73-B981-F51F46E27218 Q36156072-7A787158-37B2-49F7-B6B8-98CB4E80A9B9 Q36251994-76438729-5907-44A7-B7A7-5B9A5295CA0F Q36363027-FF5EFE58-D028-46CB-985E-99D2397238A3 Q36658777-1F97D5BD-63E0-4134-A85C-13C1F93D482D Q37021026-C146D760-5BD7-4336-9B19-47EBD5FFE1D7 Q37040505-9BA5B856-6DE6-4852-83E9-E4F6DF2637DB Q37132097-CEB52487-0245-4E8A-8747-7941E1C7A6DD Q37287247-4BFF1269-0094-48B0-978C-A21C23E48022 Q37304358-6911A48B-5C86-476A-B578-38FDFDB0FA10 Q37464141-C6C699A6-E0C8-4062-BDA0-395E123A3CBE Q37546781-A8204FFE-BA89-45B5-8384-B12CD1B6C98B Q37621704-64593C0E-69B1-4F53-96F6-82E254074061 Q37629532-E012AEC1-ACF4-441A-8CCE-BB7C09025A6A

P2860

Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

http://www.wikidata.org/entity/Q33511706

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@ast

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@en

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@nl

type

label

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@ast

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@en

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@nl

prefLabel

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@ast

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@en

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@nl

P1433

Q33511706-6DD4C55A-5933-4B83-A710-00E46FF5522F

P1476

Q33511706-72F34E92-5BE3-4288-803B-0ECBD603E137

P2093

Q33511706-1202BE6D-913E-4B1E-BECB-1DDF82F79906

Q33511706-17FF315B-9258-465C-8727-C0F816886A7C

Q33511706-3AB85A64-5810-454B-BB8D-F8CA25601700

Q33511706-43289AE1-3978-4847-AA57-BC82923D3791

Q33511706-45DB3BEA-9271-4EA8-8B50-25D7CBEB4A23

Q33511706-56AEA521-0886-4D3F-A6D9-FEDE94FD3F54

Q33511706-67945F04-61B0-4C55-8F3E-0CB25DED7705

Q33511706-7030088F-8B84-444A-86C9-D8209168A5FA

Q33511706-7B0BFE3C-9748-4C88-ACF1-C224D9CE0597

Q33511706-7B769E46-1693-43E7-91F1-763A1F207AD7

P2860

Q33511706-08C6D34B-62F3-4004-A3AF-9937106A5DAB

Q33511706-185A4532-C256-48A8-AADF-5544DFD11663

Q33511706-1C7AA212-E87F-4948-BDDD-E7DDCBD24D23

Q33511706-208F8748-ECF9-4925-B723-40E1B5E913CC

Q33511706-2182BB8C-2EF3-482B-B11D-C572843FFA2C

Q33511706-2498015A-CB9C-4F46-8660-65A77C2B491D

Q33511706-2E907BD4-E251-47EE-9F44-A2992A173D1C

Q33511706-351D3205-6D45-494A-8106-33EB6B2B4CE9

Q33511706-388592A6-1187-4977-B429-D0825A02B25A

Q33511706-4911B9E8-6DFD-47C0-82F3-A698C2351207

P304

Q33511706-8F67E248-3C14-4F1B-A1A3-BFED46600A7A

P31

Q33511706-D0F0BB0D-194D-40E9-BFE6-0AA670616AFF

P356

Q33511706-F04CAAEF-2DD7-4D34-99F5-71866148A1E2

P407

Q33511706-4FB6A5CB-A3B4-48AD-BA53-342BB68CCB03

P433

Q33511706-F1A9FBDB-E548-479B-84EB-495FAFE8A306

P478

Q33511706-56825FD5-A008-4ED5-9343-3F49367CFCA0

P50

Q33511706-40A4F43F-2D5B-4771-BC12-4C2124A830CB

Q33511706-4C8BF5B7-3DE7-4A23-BDEB-235CF1C03F95

Q33511706-62528491-F5AD-4636-8D43-05C75E1BA145

P577

Q33511706-129EFD0A-3F6A-4368-9F71-F6D7C365A3E9

P698

Q33511706-DD8B05E7-CE1A-4B5E-A23A-F0E02AD43736

P921

Q33511706-2F354CF0-4BA6-4C6B-901A-50FD162A26DD

Q33511706-3F1BE7B0-0A15-4E3F-A566-BDFBDFB21F53

Q33511706-3FF14F69-57B9-4B34-9297-A4561FDDFC8F

P932

Q33511706-3C30C5D2-425D-4D59-93A2-15B79077BB29

P356

P1433

Journal of Clinical Microbiology

P1476

Multicenter study of prevalenc ...... ith cystic fibrosis in france.

@en

P2093

Anne-Laure Roux

http://www.w3.org/2001/XMLSchema#string

Brigitte Fauroux

http://www.w3.org/2001/XMLSchema#string

Cristina Gutierrez

http://www.w3.org/2001/XMLSchema#string

Edouard Macheras

http://www.w3.org/2001/XMLSchema#string

Emilie Catherinot

http://www.w3.org/2001/XMLSchema#string

Evelyne Le Roux

http://www.w3.org/2001/XMLSchema#string

Fabienne Ripoll

http://www.w3.org/2001/XMLSchema#string

Gil Bellis

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Gaillard

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Herrmann for the OMA Group

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures

rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov

Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia

Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosis

Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.

hsp65 sequencing for identification of rapidly growing mycobacteria.

Mycobacterium abscessus and children with cystic fibrosis.

Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States.

P304

4124-4128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01257-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Didier Guillemot

Véronique Vincent

P577

2009-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19846643

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

multicenter trial

P932

2786646

http://www.w3.org/2001/XMLSchema#string